Low Volume Stocks with Momentum Worth Watching

 WallStWhiz
 
  WallStWhiz
 
Follow  Message
 
 
 
Unraveling market complexities one story at a time. Reporting on finance with integrity and insight.
 

•  01 Nov 2025
 

•   ASX  
   
  +0.56%
•   BRZE  
   
  +19.64%
•   EGAN  
   
  -28.64%
•   IBEX  
   
  +2.17%
•   IVVD  
   
  +40.34%

The best trading setups often emerge where few are looking. While mainstream media obsesses over the usual suspects, several smaller names are building serious technical momentum with minimal fanfare. These overlooked growth stocks combine modest volumes with compelling setups that could reward patient traders.

$ASX ASE Technology Holding is making noise in semiconductors with a remarkable seven-day winning streak. The stock shows overbought RSI readings above eighty, but volume confirms genuine buying interest at more than double typical levels. Trading well above all moving averages, this Taiwan-based packaging and testing provider benefits from surging AI chip demand. The extended technical condition and geopolitical risks demand careful position management despite the strong trend.

$MNMD Mind Medicine captured attention with five consecutive up days and a fresh billion-dollar market cap milestone. Trading volume more than doubled its average while RSI readings stay in healthy bullish territory without reaching extreme levels. The stock trades comfortably above both short and intermediate moving averages, suggesting sustained buying interest. The psychedelic medicine company's focus on mental health treatments positions it in a high-growth niche, though clinical trial risks and regulatory hurdles remain ever-present concerns for speculative healthcare plays.

$TSEM Tower Semiconductor also posted seven straight winning days with volume nearly double its typical pace. RSI readings approach overbought levels while the stock trades significantly above all major moving averages, marking a strong established uptrend. As a specialty semiconductor foundry, Tower benefits from diversified chip manufacturing demand, though the extended technical readings suggest a consolidation or pullback could materialize before the next leg higher.

$BRZE Braze operates in customer engagement software with recent analyst activity revealing mixed sentiment. Fifteen firms weighed in with price targets spanning a wide range, and notable upgrades came from major banks while others trimmed expectations. RSI readings indicate neutral momentum with room to run, and the stock trades near its moving averages suggesting a consolidation phase. The market appears to be digesting conflicting analyst opinions while waiting for upcoming catalysts to provide direction.

$MTLS Materialise operates in 3D printing software with recent analysis suggesting valuation upside potential. RSI readings show moderate bullish momentum while volume remains characteristically light for this smaller name. The stock trades above its moving averages confirming the uptrend, though thin liquidity makes this suitable primarily for traders comfortable with wider bid-ask spreads and potential slippage on entries and exits.

$EGAN eGain Corporation grabbed attention with a sharp surge on elevated volume in customer engagement software. RSI readings signal building momentum while the stock trades well above short and intermediate moving averages. Articles note that earnings estimate revisions may not support continued upside, suggesting the recent spike might need fundamental backing rather than just technical momentum to sustain gains.

$MGTX MeiraGTx Holdings operates in gene therapy with a big catalyst arriving when Raymond James initiated coverage with a Strong Buy rating and aggressive price target. RSI readings indicate moderate momentum while volume runs slightly below average. Trading above its moving averages, the stock shows technical strength, though aggressive analyst targets often reflect optimistic scenarios. Gene therapy remains high-risk, high-reward territory dependent on clinical success and regulatory approvals.

$MYRG MYR Group operates in utility infrastructure construction with balanced RSI momentum and volume trailing typical levels. The stock trades above all major moving averages establishing a clear uptrend with exposure to infrastructure spending tailwinds. Recent reports suggest the company doesn't possess the combination of factors typically preceding earnings beats, tempering near-term expectations despite the solid technical setup.

$IBEX IBEX Limited provides outsourcing services with recent analysis highlighting strong earnings and AI adoption. RSI readings sit in neutral territory with plenty of room to move, while light volume suggests limited institutional participation. The stock trades near short-term moving averages but well above longer-term ones, reflecting a consolidation within an intact uptrend that could set up the next directional move.

$IVVD Invivyd presents a contrarian setup after dropping five consecutive days. RSI readings sit in neutral territory despite the recent decline, while volume came in below its typically elevated average. Interestingly, the stock maintains an uptrend designation trading above all moving averages. This biotech developing antibody therapies offers a potential mean reversion play if the recent selling proves overdone, though lighter volume on the decline suggests limited conviction in either direction.

View All Headlines